After suffering a 20 percent drop in value during August and September, the BioWorld Blue Chip Biotech Index, comprising 20 of the leading companies ranked by market cap, recovered over half of its losses with an 11.5 percent jump in October. Biotech benefited from a calmer, more positive period in the capital markets with the Nasdaq Composite index and the Dow Jones Industrial Average also recording strong growth of 10 percent and 9 percent, respectively. Read More
The fact that antimicrobial resistance (AMR) represents a "ticking time bomb" and a major threat to global health is widely recognized by governments, the scientific community and the biopharmaceutical industry alike. Yet, despite that consensus, advocacy groups focusing on the problem argue that when all is said and done there is more being said than done. As a result, the pace of progress and the amount investments being made in research and development need to be accelerated. Read More
The American Association for Cancer Research (AACR), the National Cancer Institute (NCI) and the European Organisation for Research and Treatment of Cancer (EORTC), are teaming up to put on the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics scheduled to kick off on Thursday. Read More
